Skip to main content
. 2013 Feb 28;8(2):e58193. doi: 10.1371/journal.pone.0058193

Figure 6. Fascaplysin inhibits growth of ARMS cells.

Figure 6

A) ARMS cells (Rh30 and Rh41) and ERMS cells (RD and JR1) were treated with 0.69 µM fascaplysin for indicated times before cell viability was determined. Fascaplysin at 0.69 µM started to inhibit cell viability of Rh30 cells as shown in Figure 1B. B) Cdk4 levels in various cell lines.